Grace Therapeutics (GRCE) Shares Issued (2018 - 2026)
Grace Therapeutics (GRCE) posted Shares Issued of $942632.0 for Q1 2026, down 27.79% sequentially from $1.3 million in Q4 2025, and up 0.82% YoY from $934923.0 in Q1 2025.
Grace Therapeutics (GRCE) Shares Issued (2018 - 2026) Analysis & Trends
Grace Therapeutics has reported Shares Issued for 9 years, with the latest figure at $942632.0 in Q1 2026.
- Quarterly Shares Issued rose 0.82% year-over-year to $942632.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $942632.0 (up 0.82% YoY) and the FY2026 annual result came in at $942632.0, up 0.82% from the prior year.
- Shares Issued slipped to $942632.0 in Q1 2026 per GRCE's latest filing, from $1.3 million in the prior quarter.
- Over five years, Shares Issued peaked at $4.4 million in Q4 2022 and troughed at $217480.0 in Q3 2023.
- A 5-year average of $1.2 million and a median of $934923.0 in 2024 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2023 and 2024: Shares Issued tumbled 86.27% in 2023, then soared 520.75% in 2024.
- Over 5 years, Shares Issued stood at $4.4 million in 2022, then slumped by 83.76% to $721793.0 in 2023, then gained by 29.53% to $934923.0 in 2024, then jumped by 39.63% to $1.3 million in 2025, then slipped by 27.79% to $942632.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $942632.0, $1.3 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Grace Therapeutics | 37.72 Mn | 37.72 Mn | - | 1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.35 Mn |
| Jun 30, 2026 | 1.35 Mn |
| Mar 31, 2026 | 942,632.00 |
| Mar 31, 2026 | 942,632.00 |
| Dec 31, 2025 | 1.31 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 674,890.00 |
| Jun 30, 2025 | 674,890.00 |
| Mar 31, 2025 | 934,923.00 |
| Mar 31, 2025 | 934,923.00 |
| Dec 31, 2024 | 934,923.00 |
| Dec 31, 2024 | 934,923.00 |
| Sep 30, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | 378,174.00 |
| Jun 30, 2024 | 378,174.00 |
| Mar 31, 2024 | 721,793.00 |
| Mar 31, 2024 | 721,793.00 |